Prevenar Post-Licensure Safety Study in Russia: Frequency of Fever Post Vaccination

Phase 4, open-label, single-arm trial of pneumococcal 7-valent conjugate vaccine in pneumococcal disease, pneumococcal septicemia, pneumococcal meningitis and 3 more, sponsored by Pfizer. Primary endpoint: Incidence of febrile reactions ≥38.0°C.